Pharmaceutical

Cyltezo Pen: first interchangeable biosimilar to Humira rolls out across US

The Humira biosimilar from Boehringer Ingelheim launches amidst a loss of exclusivity for AbbieVie’s blockbuster drug.

Jul 3, 2023 - 20:00
Cyltezo Pen: first interchangeable biosimilar to Humira rolls out across US
The Humira biosimilar from Boehringer Ingelheim launches amidst a loss of exclusivity for AbbieVie’s blockbuster drug.
Read the original article

Tags:

Previous Article

Generative AI – beyond the hype

Next Article

Eli Lilly’s retatrutide sets new record for weight loss in obesity space

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Bristol drug reduces reliance on transfusions for people with chronic blood disorder

STAT+: Bristol drug reduces reliance on transfusions fo...

May 25, 2023

Arcus Biosciences obtains loan facility with Hercules Capital worth $250m

Arcus Biosciences obtains loan facility with Hercules C...

Aug 29, 2024

STAT+: Annexon’s trial of an eye disease drug missed by a mile. The company saw a bull’s eye

STAT+: Annexon’s trial of an eye disease drug missed by...

May 25, 2023